Trump family’s crypto venture sparks conflict of interest concerns
Digital tokens tied to World Liberty Financial, the cryptocurrency launched by former President Donald Trump alongside his family during his […]
September 2, 2025
Market Might Still Lack Some Conviction On KoBioLabs, Inc (KOSDAQ:348150) Even After 36% Share Price Boost
The KoBioLabs, Inc (KOSDAQ:348150) share price has done very well over the last month, posting an excellent gain of 36%.
Trump family’s crypto venture sparks conflict of interest concerns
Digital tokens tied to World Liberty Financial, the cryptocurrency launched by former President Donald Trump alongside his family during his
TOP MATERIAL Co., Ltd’s (KOSDAQ:360070) stock price dropped 12% last week; retail investors would not be happy
Key Insights Significant control over TOP MATERIAL by retail investors implies that the general public has more power to influence
A New Era for Institutional Adoption?
Australia’s pension system is undergoing a quiet revolution. By mid-2025, self-managed superannuation funds (SMSFs) have allocated A$1.7 billion to cryptocurrencies,
Asax Co., Ltd.’s (TSE:8772) Share Price Boosted 27% But Its Business Prospects Need A Lift Too
Asax Co., Ltd. (TSE:8772) shareholders have had their patience rewarded with a 27% share price jump in the last month.
Trump Family’s Crypto Token Just Made Them $5 Billion Richer
The Trump family just became $5 billion richer (on paper) thanks to its latest crypto venture. The Trumps’ new digital
PLTR Holds $157 After 18% Drop
NASDAQ:PLTR Faces Volatility as Insider Sales and Valuation Fears Pressure Momentum Palantir Technologies Inc. NASDAQ:PLTR entered September trading with renewed
Cardano & Pi Network Holders Rush To Enter Early Stages Of This Record-Breaking Crypto Presale Remittix
Disclaimer: This is a Press Release provided by a third party who is responsible for the content. Please conduct your
Stock Analysis | Insulet Outlook
Market Snapshot Takeaway: Insulet (PODD.O) remains in a state of technical neutrality, with a mixed analyst outlook that contrasts with